MedTrace Logo

A Qualitative Study on the Pain and Quality of Life of Patients With Fabry Disease

NCT05679076 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2023-01-20

No results posted yet for this study

Summary

Background It is necessary to find out the difficulties experienced by patients with Fabry disease and their families, and to seek solutions for them. For this purpose, qualitative research with a patient-centered approach is useful.

Objectives The Objective of this study is to understand the various difficulties of patients with Fabry disease and to help them establish a comprehensive support system, medical, health, and welfare service system, and develop the direction and components of social and educational programs.

Methods The subjects of this study are patients who have been diagnosed with Fabry disease, and among them, are selected considering the selection and exclusion criteria, confirm consent for participation in the study after sufficient explanation, and then enroll. The target number of subjects is 10 people. Subjects who consented to the study had an in-depth interview centered on the in-depth interview questionnaire through the HA Research Institute, a specialized institution.

* The principle of saturation is observed by conducting 3 interviews per research subject.
* The duration of each interview per research subject is 50 to 60 minutes.
* All dictations of the research subjects were recorded with prior consent and then transcribed into a written copy.
* For 3 interviews, the number of interviews can be reduced to 1 or 2 by extending the interview time according to the research subject's request.
* As for the place of interview, the research counseling room at Severance Cardiovascular Hospital or the in-depth interview room in the HA Research Institute can be used, and the interview can be conducted at other places desired by the research subject at the request of the research subject.

Conditions

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Geu-Ru Hong · Severance Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-11
Primary Completion
2023-05-12
Completion
2023-05-12

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05679076 on ClinicalTrials.gov